Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17662605rdf:typepubmed:Citationlld:pubmed
pubmed-article:17662605lifeskim:mentionsumls-concept:C0205378lld:lifeskim
pubmed-article:17662605lifeskim:mentionsumls-concept:C0596902lld:lifeskim
pubmed-article:17662605lifeskim:mentionsumls-concept:C0220839lld:lifeskim
pubmed-article:17662605lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:17662605pubmed:issue18lld:pubmed
pubmed-article:17662605pubmed:dateCreated2007-8-22lld:pubmed
pubmed-article:17662605pubmed:abstractTextQuinoline-2,4-dicarboxylic acids (QDCs) bearing lipophilic substituents in the 6- or 7-position were shown to be inhibitors of the glutamate vesicular transporter (VGLUT). Using the arrangement of the QDC lipophilic substituents as a template, libraries of X(1)X(2)EF and X(1)X(2)EW tetrapeptides were synthesized and tested as VGLUT inhibitors. The peptides QIEW and WNEF were found to be the most potent. Further stereochemical deconvolution of these two peptides showed dQlIdElW to be the best inhibitor (K(i)=828+/-252 microM). Modeling and overlay of the tetrapeptide inhibitors with the existing pharmacophore showed that H-bonding and lipophilic residues are important for VGLUT binding.lld:pubmed
pubmed-article:17662605pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:languageenglld:pubmed
pubmed-article:17662605pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:citationSubsetIMlld:pubmed
pubmed-article:17662605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17662605pubmed:statusMEDLINElld:pubmed
pubmed-article:17662605pubmed:monthSeplld:pubmed
pubmed-article:17662605pubmed:issn0960-894Xlld:pubmed
pubmed-article:17662605pubmed:authorpubmed-author:ThompsonCharl...lld:pubmed
pubmed-article:17662605pubmed:authorpubmed-author:NagyJon OJOlld:pubmed
pubmed-article:17662605pubmed:authorpubmed-author:PatelSarjubha...lld:pubmed
pubmed-article:17662605pubmed:authorpubmed-author:GerdesJohn...lld:pubmed
pubmed-article:17662605pubmed:authorpubmed-author:BolstadErin...lld:pubmed
pubmed-article:17662605pubmed:issnTypePrintlld:pubmed
pubmed-article:17662605pubmed:day15lld:pubmed
pubmed-article:17662605pubmed:volume17lld:pubmed
pubmed-article:17662605pubmed:ownerNLMlld:pubmed
pubmed-article:17662605pubmed:authorsCompleteYlld:pubmed
pubmed-article:17662605pubmed:pagination5125-8lld:pubmed
pubmed-article:17662605pubmed:dateRevised2011-8-1lld:pubmed
pubmed-article:17662605pubmed:meshHeadingpubmed-meshheading:17662605...lld:pubmed
pubmed-article:17662605pubmed:meshHeadingpubmed-meshheading:17662605...lld:pubmed
pubmed-article:17662605pubmed:meshHeadingpubmed-meshheading:17662605...lld:pubmed
pubmed-article:17662605pubmed:year2007lld:pubmed
pubmed-article:17662605pubmed:articleTitleTetrapeptide inhibitors of the glutamate vesicular transporter (VGLUT).lld:pubmed
pubmed-article:17662605pubmed:affiliationCenter for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, The University of Montana, Missoula, MT 59812, USA.lld:pubmed
pubmed-article:17662605pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17662605pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17662605lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17662605lld:pubmed